Today at the American College of Rheumatology (ACR) Annual Meeting, Convergence 2024, the ACR released a summary of a new guideline for the screening, treatment and management of lupus nephritis ...

The ACR recently released the full 2024 guideline on the management of LN, the first of its kind since 2012.

They also conditionally recommend performing a kidney biopsy in patients with SLE who have high levels of protein in the urine (> 0.5 g/g) and/or impaired kidney function not otherwise explained.

Renal arteriosclerosis found in kidney biopsy specimens at lupus nephritis (LN) diagnosis is an early risk factor for future cardiovascular disease (CVD) events, investigators reported at the ...

A type of lab test called a "core-needle biopsy" may be better for certain kidney cancer patients, new research suggests.

The ACR panel, which developed the guidelines, recommends renal biopsy for all patients with clinical evidence of active, previously untreated LN.

When asked how the decision to perform a kidney biopsy was determined, nephrologists responded with substantial variability. According to data published in Kidney Medicine, several factors go into ...

Techcyte is proud to share results from a published pilot study demonstrating the effectiveness of its AI-powered kidney ...

The first guidelines ever developed for managing lupus nephritis recommend kidney biopsies for all patients and the use of rituximab for refractive disease, although it is not approved for that use.